Can-Fite Biopharma (CANF) Q2 2024 Earnings

May 30Confirmed
Nov 2022
Q4 2022
Q1 2023
Q2 2024
-1.1
-0.73
-0.37
0

Details

Expected EPS
-0.001349
Actual EPS
-0.001166
Surprise EPS
0
Surprise Percent
+13.57%

Description

⁨Can-Fite Biopharma⁩ (⁦CANF⁩) has reported earnings of ⁦-0.001166⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts